Integral Ad Science [IAS] vs Emerald Holding [EEX] Detailed Stock Comparison

Integral Ad Science
NASDAQ
Loading...

Emerald Holding
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Integral Ad Science wins in 12 metrics, Emerald Holding wins in 6 metrics, with 0 ties. Integral Ad Science appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | Integral Ad Science | Emerald Holding | Better |
---|---|---|---|
P/E Ratio (TTM) | 30.84 | 120.25 | Integral Ad Science |
Price-to-Book Ratio | 1.38 | 2.45 | Integral Ad Science |
Debt-to-Equity Ratio | 2.59 | 132.36 | Integral Ad Science |
PEG Ratio | 26.31 | 40.08 | Integral Ad Science |
EV/EBITDA | 10.94 | 11.27 | Integral Ad Science |
Profit Margin (TTM) | 9.78% | 1.83% | Integral Ad Science |
Operating Margin (TTM) | 10.17% | 13.08% | Emerald Holding |
EBITDA Margin (TTM) | 10.17% | 13.08% | Emerald Holding |
Return on Equity | 5.52% | 1.98% | Integral Ad Science |
Return on Assets (TTM) | 3.91% | 4.87% | Emerald Holding |
Free Cash Flow (TTM) | $77.35M | $37.00M | Integral Ad Science |
Dividend Yield | N/A | 0.62% | N/A |
1-Year Return | -15.28% | -9.07% | Emerald Holding |
Price-to-Sales Ratio (TTM) | 2.59 | 2.20 | Emerald Holding |
Enterprise Value | $1.25B | $1.31B | Emerald Holding |
EV/Revenue Ratio | 2.20 | 3.03 | Integral Ad Science |
Gross Profit Margin (TTM) | 77.53% | 61.52% | Integral Ad Science |
Revenue per Share (TTM) | $3 | $2 | Integral Ad Science |
Earnings per Share (Diluted) | $0.29 | $0.04 | Integral Ad Science |
Beta (Stock Volatility) | N/A | 1.15 | N/A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Integral Ad Science vs Emerald Holding Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Integral Ad Science | 12.81% | 14.25% | 8.59% | 15.28% | -16.39% | -15.12% |
Emerald Holding | -3.02% | -1.03% | -7.50% | 3.22% | 9.32% | 1.48% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Integral Ad Science | -15.28% | -14.07% | -52.11% | -52.11% | -52.11% | -52.11% |
Emerald Holding | -9.07% | 12.65% | 68.77% | -75.33% | -75.33% | -75.33% |
Performance & Financial Health Analysis: Integral Ad Science vs Emerald Holding
Metric | IAS | EEX |
---|---|---|
Market Information | ||
Market Cap | $1.48B | $952.25M |
Market Cap Category | Small cap | Small cap |
10 Day Avg. Volume | 776,304 | 52,310 |
90 Day Avg. Volume | 745,831 | 68,820 |
Last Close | $8.98 | $4.81 |
52 Week Range | $6.26 - $13.62 | $3.21 - $6.65 |
% from 52W High | -34.07% | -27.67% |
All-Time High | $29.68 (Nov 08, 2021) | $24.56 (Oct 02, 2017) |
% from All-Time High | -69.74% | -80.42% |
Growth Metrics | ||
Quarterly Revenue Growth | 0.16% | 0.23% |
Quarterly Earnings Growth | 1.13% | 0.23% |
Financial Health | ||
Profit Margin (TTM) | 0.10% | 0.02% |
Operating Margin (TTM) | 0.10% | 0.13% |
Return on Equity (TTM) | 0.06% | 0.02% |
Debt to Equity (MRQ) | 2.59 | 132.36 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | $6.50 | $1.97 |
Cash per Share (MRQ) | $0.55 | $0.79 |
Operating Cash Flow (TTM) | $151.86M | $58.20M |
Levered Free Cash Flow (TTM) | $118.19M | $78.43M |
Dividends | ||
Last 12-Month Dividend Yield | N/A | 0.62% |
Last 12-Month Dividend | N/A | $0.03 |
Valuation & Enterprise Metrics Analysis: Integral Ad Science vs Emerald Holding
Metric | IAS | EEX |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 30.84 | 120.25 |
Forward P/E | 26.31 | 40.08 |
PEG Ratio | 26.31 | 40.08 |
Price to Sales (TTM) | 2.59 | 2.20 |
Price to Book (MRQ) | 1.38 | 2.45 |
Market Capitalization | ||
Market Capitalization | $1.48B | $952.25M |
Enterprise Value | $1.25B | $1.31B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 2.20 | 3.03 |
Enterprise to EBITDA | 10.94 | 11.27 |
Risk & Other Metrics | ||
Beta | N/A | 1.15 |
Book Value per Share (MRQ) | $6.50 | $1.97 |
Financial Statements Comparison: Integral Ad Science vs Emerald Holding
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | IAS | EEX |
---|---|---|
Revenue/Sales | $134.07M | $105.50M |
Cost of Goods Sold | $30.13M | $40.60M |
Gross Profit | $103.94M | $64.90M |
Research & Development | $19.70M | N/A |
Operating Income (EBIT) | $9.45M | $10.20M |
EBITDA | $25.92M | $19.10M |
Pre-Tax Income | $11.38M | $600,000 |
Income Tax | $3.39M | $2.00M |
Net Income (Profit) | $7.99M | $-1.40M |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | IAS | EEX |
---|---|---|
Cash & Equivalents | $59.12M | $276.80M |
Total Current Assets | $238.34M | $413.60M |
Total Current Liabilities | $59.37M | $260.10M |
Long-Term Debt | $27.48M | $507.30M |
Total Shareholders Equity | $1.04B | $392.10M |
Retained Earnings | $54.74M | $-634.80M |
Property, Plant & Equipment | $18.81M | $5.80M |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | IAS | EEX |
---|---|---|
Operating Cash Flow | $10.58M | $-6.00M |
Capital Expenditures | $-554,000 | $-200,000 |
Free Cash Flow | $-7.37M | $10.80M |
Debt Repayment | $-20.00M | $-169.50M |
Common Stock Repurchase | N/A | $-8.80M |
Short Interest & Institutional Ownership Analysis
Metric | IAS | EEX |
---|---|---|
Shares Short | 8.29M | 934,884 |
Short Ratio | 10.57 | 10.09 |
Short % of Float | 0.11% | 0.07% |
Average Daily Volume (10 Day) | 776,304 | 52,310 |
Average Daily Volume (90 Day) | 745,831 | 68,820 |
Shares Outstanding | 162.87M | 201.45M |
Float Shares | 75.82M | 12.51M |
% Held by Insiders | 0.01% | 0.01% |
% Held by Institutions | 0.97% | 0.99% |
Dividend Analysis & Yield Comparison: Integral Ad Science vs Emerald Holding
Metric | IAS | EEX |
---|---|---|
Last 12-Month Dividend | N/A | $0.03 |
Last 12-Month Dividend Yield | N/A | 0.62% |
3-Year Avg Annual Dividend | N/A | $0.01 |
3-Year Avg Dividend Yield | N/A | 0.32% |
3-Year Total Dividends | N/A | $0.03 |
Ex-Dividend Date | N/A | Mar 10, 2025 |